Matthijs L. Siegenbeek van Heukelom

Purine Nucleoside Phosphorylase Deficiency Associated with Selective Cellular Immunodeficiency

J. W. Stoop, B.J.M. Zegers, G. F. M. Hendrickx et al. · New England Journal of Medicine · 1977 · 196 citations

Life Sciences, Biochemistry, Immunology +16

Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas

Jettie J.F. Muris, C J Meijer, Saskia A.G.M. Cillessen et al. · Leukemia · 2003 · 97 citations

Medicine, Oncology, Pathology +10

HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM

Karien C.M. Gosens, Ramon P van der Zee, Matthijs L. Siegenbeek van Heukelom et al. · AIDS · 2021 · 42 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +14

Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.

G.E.J. Staal, J. W. Stoop, B.J.M. Zegers et al. · Journal of Clinical Investigation · 1980 · 41 citations · Full text

Life Sciences, Biochemistry, Immunology +14

An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity

Matthijs L. Siegenbeek van Heukelom, G.E.J. Staal, J. W. Stoop et al. · Clinica Chimica Acta · 1976 · 37 citations

Life Sciences, Immunology, Molecular Genetics +14